Bioinspired Manufacturing of hiPSC-based Therapy Products for application in Cardiovascular Regenerative Medicine

被引：0
|
作者：
Serra, M. [1 ,4 ]
Abecasis, B. [2 ,4 ]
Correia, C. [2 ,4 ]
Hu, D. [3 ]
Sebastiao, M. J. [2 ,4 ]
Paiva, M. A. [2 ,4 ]
Almeida, H. V. [2 ,4 ]
Gomes-Alves, P. [2 ,4 ]
Elliott, D. [5 ]
Teixeira, A. [2 ,4 ]
Domian, I. [3 ]
Alves, P. [2 ,4 ]
机构：
[1] iBET Inst Biol Expt Tecnol, Pharma & Hlth, Oeiras, Portugal
[2] IBET, Oeiras, Portugal
[3] Harvard Stem Cell Inst, Cambridge, MA USA
[4] ITQB NOVA, Oeiras, Portugal
[5] Murdoch Childrens Res Inst, Parkville, Vic, Australia
来源：
CYTOTHERAPY | 2020年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
326
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [1] Bioreactor Technology for Cell Therapy Manufacturing in Regenerative Medicine
    Zhang, Hu
    Kent, David E.
    Albanna, Mohammad
    Lhu, Lexan
    Sun, Xiuzhi Susan
    Eaker, Shannon
    Somara, Sita
    CURRENT STEM CELL REPORTS, 2021, 7 (04) : 212 - 218
  • [2] Bioreactor Technology for Cell Therapy Manufacturing in Regenerative Medicine
    Hu Zhang
    David E. Kent
    Mohammad Albanna
    Lexan Lhu
    Xiuzhi Susan Sun
    Shannon Eaker
    Sita Somara
    Current Stem Cell Reports, 2021, 7 : 212 - 218
  • [3] Overview of the clinical application of regenerative medicine products in Japan
    Tsubouchi, Mina
    Matsui, Shigeyuki
    Banno, Yoshiro
    Kurokawa, Kiyoshi
    Kawakami, Koji
    HEALTH POLICY, 2008, 88 (01) : 62 - 72
  • [4] Immunocompetent hiPSC-Based 3D Models to Study Innate Immune Response to Gene Therapy Vectors
    Gomes, Catarina Monteiro
    Silva, Gabriela
    Holtkamp, Stephan
    Trautwein, Mark
    Simao, Daniel
    Alves, Paula Marques
    Brito, Catarina
    MOLECULAR THERAPY, 2024, 32 (04) : 836 - 836
  • [5] Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
    Nagako Sougawa
    Shigeru Miyagawa
    Satsuki Fukushima
    Ai Kawamura
    Junya Yokoyama
    Emiko Ito
    Akima Harada
    Kaori Okimoto
    Noriko Mochizuki-Oda
    Atsuhiro Saito
    Yoshiki Sawa
    Scientific Reports, 8
  • [6] Natural Products as Regulators of Progenitor Cells: Role in Cardiovascular Regenerative Medicine
    Kumar, A. H. S.
    Hynes, B. G.
    Ahmed, Mueen K. K.
    JOURNAL OF YOUNG PHARMACISTS, 2009, 1 (01) : 28 - 35
  • [7] Immunologic Targeting of CD30 Eliminates Tumorigenic Human Pluripotent Stem Cells (iPSC) Allowing Safer Clinical Application of hiPSC-Based Therapy
    Sougawa, Nagako
    Masuda, Shigeo
    Miyagawa, Shigeru
    Fukushima, Satsuki
    Ito, Emiko
    Saito, Atsuhiro
    Sawa, Yoshiki
    CIRCULATION, 2014, 130
  • [8] Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
    Sougawa, Nagako
    Miyagawa, Shigeru
    Fukushima, Satsuki
    Kawamura, Ai
    Yokoyama, Junya
    Ito, Emiko
    Harada, Akima
    Okimoto, Kaori
    Mochizuki-Oda, Noriko
    Saito, Atsuhiro
    Sawa, Yoshiki
    SCIENTIFIC REPORTS, 2018, 8
  • [9] Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study
    Richman, Sara
    Gee, Adrian P.
    McKenna, David H.
    Traverse, Jay H.
    Henry, Timothy D.
    Fisk, Diann
    Pepine, Carl J.
    Bloom, Jeannette
    Willerson, James T.
    Prater, Karen
    Zhao, David
    Koc, Jane Reese
    Anwaruddin, Saif
    Taylor, Doris A.
    Cogle, Christopher R.
    Moye, Lemuel A.
    Simari, Robert D.
    Skarlatos, Sonia I.
    TRANSFUSION, 2012, 52 (10) : 2225 - 2233
  • [10] Deconstructing Regenerative Medicine: From Mechanistic Studies of Cell Therapy to Novel Bioinspired RNA Drugs
    Marban, Eduardo
    CIRCULATION RESEARCH, 2024, 135 (08) : 877 - 885
12345